(Q42284197)

19 October 2017

title

Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus (English)

1 reference

19 October 2017

0 references

1 reference

Christian L Jacob

1

1 reference

19 October 2017

Louie Lamorte

2

1 reference

19 October 2017

Eliud Sepulveda

3

1 reference

19 October 2017

Ivo C Lorenz

4

1 reference

19 October 2017

Annick Gauthier

5

1 reference

19 October 2017

Michael Franti

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

9 July 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

444

1 reference

19 October 2017

issue

1-2

1 reference

19 October 2017

page(s)

140-147

1 reference

Role of human cytomegalovirus UL131A in cell type-specific virus entry and release

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Editorial commentary: Primary maternal cytomegalovirus infection during pregnancy: do we have a treatment option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human CMV-IGIV (CytoGam) neutralizes human cytomegalovirus (HCMV) infectivity and prevents intracellular signal transduction after HCMV exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Cytomegalovirus: pathogen, paradigm, and puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Antibodies, viruses and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Evidence for direct transfer of cytoplasmic material from infected to uninfected cells during cell-associated spread of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Avoiding the void: cell-to-cell spread of human viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Effect of serum and CTL on focal growth of human cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.06.002

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2013.06.002

1 reference

19 October 2017

1 reference